COVID - 19 Webinars
Talking to customers across Asia, Europe and the US, the most common question we get asked is: “What’s everyone else doing?”
In this free-ranging conversation the TRI team discuss that and other questions like: “What do winners and losers look like after COVID-19?”; and “What are clients doing that’s benefiting them?”
This is an informal discussion with some real gems, insights and practical advice from people who really understand the problems COVID-19 is causing clinical trials. Enjoy.